| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |